RedChip Companies
|
|
Weekly Newsletter
|
|
Lantern Pharma Receives FDA Clearance of IND Application for Drug Candidate LP-184 in Solid Tumors
|
Lantern Pharma (Nasdaq: LTRN), an artificial intelligence ("AI") company developing targeted and transformative cancer therapies using its proprietary RADR® AI and machine learning (“ML”) platform with multiple clinical stage drug programs, today announced that the U.S. Food and Drug Administration (FDA) has cleared the investigational new drug (IND) application for LP-184, which is being developed for multiple advanced solid tumors and central nervous system (CNS) cancers. The first-in-human Phase 1A trial for LP-184 is anticipated to launch and dose its first patient during the current quarter.
For more information, visit www.lanternpharma.com
|
Graphex Technologies Launches Its Strategic Advisory Committee
Graphex Technologies LLC, a wholly owned subsidiary of Graphex Group Limited (collectively “Graphex” or the “Company”)) (NYSE American: GRFX | HKSE: 6128) and a global leader in mid-stream processing of natural graphite for use in Lithium-ion (Li-ion) powered batteries, today announced the formation of its U.S. strategic advisory committee as it continues to move forward with its business objectives to establish end-to-end graphite processing and production capabilities in North America and beyond. The advisory committee is being formed to provide advice and consultation by professionals across multiple industries to accelerate Graphex’s business opportunities. It is expected that shares of Graphex that are granted to the advisors will be subject to a 12-month lock-up restriction.
|
Genius Group Launches Genius Metaversity in Partnership with Vatom
Genius Group (NYSE American: GNS) (“Genius Group” or the “Company”), a leading entrepreneur edtech and education group, has launched Genius Metaversity, a virtual reality learning environment in partnership with Vatom to hold educational courses and summits in the Metaverse. Genius Group’s Global AI Investor Summit held on June 2 and June 3, 2023 was the first event hosted in the Metaversity via the Vatom platform and was a great success with around 2,000+ attendees from around the world joining with their own virtual avatars, connecting in a global classroom, interacting with speakers and joining courses and programs.
|
|
|
Inspira™ Technologies Unveils Investor Deck Showcasing Revolutionary Advancement in Acute Respiratory Care
Inspira™ Technologies OXY B.H.N. Ltd. (Nasdaq: IINN) (Nasdaq: IINNW) (the "Company" or "Inspira Technologies"), a company aiming to revolutionize acute respiratory care, is thrilled to present our latest investor deck, unveiling unparalleled opportunities that have the potential to reshape the acute respiratory care landscape introducing empowered breathing without the use of lungs.
|
Unicycive to Participate in the Healthcare Virtual Conference Presented by Maxim Group LLC and hosted by M-Vest on Tuesday, June 20th to Thursday, June 22nd at 9:00 A.M. ET
Unicycive Therapeutics, Inc. (Nasdaq: UNCY), a clinical-stage biotechnology company developing therapies for patients with kidney disease, announced today that Company CEO, Shalabh Gupta, MD, has been invited to present at the Healthcare Virtual Conference Part II, presented by Maxim Group LLC and hosted by M-Vest, on Tuesday, June 20th to Thursday, June 22nd at 9:00 A.M. ET
|
|
|
Upcoming Events |
|
|
|
|
| NASDAQ: IINN - Inspira Technologies |
| 11:00am Eastern |
| Inspira Technologies Oxy BHN Ltd is a specialty medical device company engaged in the research, development, manufacture, and marketing of proprietary respiratory support technology that is intended to provide an alternative to invasive mechanical ventilation (MV), which is the standard of care today for the treatment of respiratory failure. |
|
|
|
|
|
| NASDAQ: ASPI - ASP Isotopes |
| 4:15pm Eastern |
| ASP Isotopes Inc is a pre-commercial stage advanced materials company dedicated to the development of technology and processes that, if successful, will allow for the production of isotopes that may be used in several industries. |
|
|
|
|
|
| NASDAQ: BFRG - BullFrog AI |
| 4:15pm Eastern |
| BullFrog AI is a digital technology company using machine learning to usher in a new era of precision medicine. |
|
|
|
|
|
| OTC: EBZT - Everything Blockchain |
| 4:15pm Eastern |
| Everything Blockchain is a development, engineering, and services company specializing in Blockchain technologies and decentralized processing. |
|
|
|
|
|
| NASDAQ: SPI - SPI Energy |
| 4:15pm Eastern |
| SPI Energy is a global renewable energy company and provider of solar storage and electric vehicle (EV) solutions that was founded in 2006 in Roseville, California and is headquartered in McClellan Park, California. |
|
|
|
|
|
| NASDAQ: BIVI - BioVie |
| 4:15pm Eastern |
| BioVie Inc. (NASDAQ: BIVI) is a clinical-stage company developing what it believes will be transformative therapies to overcome unmet medical needs in neurodegeneration and liver disease. |
|
|
|
|
|
| OTCQB: QYOUF - QYOU Media |
| 4:15pm Eastern |
| QYOU Media operates in India and the United States producing and distributing content created by social media stars and digital content creators. |
|
|
|
|
|
| NASDAQ: SNGX - Soligenix |
| 4:15pm Eastern |
| Soligenix Inc is a late-stage biopharmaceutical company based in the United States. It focuses on developing and commercializing products to treat rare diseases where there is an unmet medical need. |
|
|
|
|
|
| NYSE American: GRFX - Graphex Group |
| 4:15pm Eastern |
| Graphex Group is a global leader in the mid-stream deep processing of natural spherical graphite and graphene-related products, key components of the Lithium-ion (Li-ion) batteries used in Electric Vehicles (EVs), renewable energy storage systems, and other use cases. |
|
|
Archive Events |
|
|
|
|
| NASDAQ: ARDS - Aridis Pharmaceuticals |
| Meeting Duration 48 minutes |
| Aridis Pharmaceuticals, Inc. discovers and develops novel anti-infective therapies to treat life-threatening infections, including anti-infectives to be used as add-on treatments to standard-of-care antibiotics. |
|
|
|
|
|
| NASDAQ: RVSN - Rail Vision |
| Meeting Duration 36 minutes |
| Rail Vision is the leading provider of obstacle detection and classification systems in the railway industry. |
|
|
|
|
|
| NYSE American: GNS - Genius Group |
| Meeting Duration 44 minutes |
| Genius Group is a world leading entrepreneur Edtech and education group, with a mission to disrupt the current education model with a student-centered, life-long learning curriculum that prepares students with the leadership, entrepreneurial and life skills to succeed in today’s market. |
|
|
|
|
|
| NASDAQ: ALAR - Alarum Technologies |
| Meeting Duration 36 minutes |
| Alarum Technologies Ltd. is an Israel-based company engaged in the information security business. It controls and secures data exchange, preventing data exfiltration, leakage, malware, ransomware, and fraud. |
|
|
|
|
|
| NASDAQ: STSS - Sharps Technology |
| Meeting Duration 48 minutes |
| Sharps Technology is a medical device and pharmaceutical packaging company specializing in the development and manufacturing of innovative drug delivery systems. |
|
|
|
|
|
| NASDAQ: LTRN - Lantern Pharma |
| Meeting Duration 34 minutes |
| Lantern Pharma is a clinical stage oncology-focused company who is harnessing the power of Artificial Intelligence and Genomics to develop precision cancer therapies. |
|
|
|
|
|
| NASDAQ: SNGX - Soligenix |
| Meeting Duration 48 minutes |
| Soligenix Inc is a late-stage biopharmaceutical company based in the United States. It focuses on developing and commercializing products to treat rare diseases where there is an unmet medical need. |
|
|
|
|
|
| NASDAQ: SPI - SPI Energy |
| Meeting Duration 145 minutes |
| We are delighted to invite you to SPI Energy's Investor Day 2023, where you will have the chance to learn more about our strategic vision and growth plans and hear from key members of our leadership team. |
|
|
|
|
|
| NASDAQ: BIVI - BioVie |
| Meeting Duration 43 minutes |
| BioVie Inc. (NASDAQ: BIVI) is a clinical-stage company developing what it believes will be transformative therapies to overcome unmet medical needs in neurodegeneration and liver disease. |
|
|
|
|
|
| NASDAQ: BFRG - BullFrog AI |
| Meeting Duration 35 minutes |
| BullFrog AI is a digital technology company using machine learning to usher in a new era of precision medicine. |
|
|
|
|
|
| NASDAQ: UNCY - Unicycive Therapeutics |
| Meeting Duration 28 minutes |
| Unicycive Therapeutics Inc is a biotechnology company dedicated to developing treatments for certain medical conditions. |
|
|
|
|
|
| NASDAQ: ASPI - ASP Isotopes |
| Meeting Duration 32 minutes |
| ASP Isotopes Inc is a pre-commercial stage advanced materials company dedicated to the development of technology and processes that, if successful, will allow for the production of isotopes that may be used in several industries. |
|
|
Lesson of the Week
Learn how fear and greed impact investing.
|
|
|
MidSouth Week in Review
The 5-year Treasuries hit 4% for the first time since March. Bitcoin dropped below 25k.
|
|
|
You are receiving this email because your email is subscribed to our mailing list.
Click here to update your subscription or unsubscribe your email address.
Copyright © 2023. All rights reserved.
|
|
© 2023 RedChip , All rights reserved
|
|
| |
|
|
